LY-2456302, CAS 1174130-61-0 Sole GMP Manufacturer

LY-2456302, CAS 1174130-61-0  Sole GMP Manufacturer

LY-2456302, CAS 1174130-61-0  stable novel crystalline or amorphous form both we have, LY-2456302, CAS 1174130-61-0 no any IP problem. LY-2456302, CAS 1174130-61-0  DMF filling, free sample of LY-2456302, CAS 1174130-61-0 .

EOS Med Chem have already carried out LY-2456302, CAS 1174130-61-0  batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For LY-2456302, CAS 1174130-61-0  , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.

Below is LY-2456302, CAS 1174130-61-0  Intermeidates list, most from GMP plant:

LY-2456302, CAS 1174130-61-0 Intermediate,  64248-62-0, stock 1.2kg, assay 98.8%, White powder.

LY-2456302, CAS 1174130-61-0 Intermediate,  676494-55-6, stock 3.6kg, assay 98.9%, White powder.

LY-2456302, CAS 1174130-61-0 Intermediate,  676494-56-7, stock 7.6kg, assay 98.3%, White powder.

LY-2456302, CAS 1174130-61-0 Intermediate,  383127-44-4, stock 7kg, assay 98.7%, White powder.

LY-2456302, CAS 1174130-61-0 Intermediate,  1174130-60-9, stock 3.8kg, assay 98.3%, White powder.

LY-2456302, CAS 1174130-61-0 Intermediate,  1174130-61-0, stock 3.3kg, assay 98.2%, White powder.

LY-2456302, CAS 1174130-61-0  HNMR, MASS, COA, MSDS we have.

LY-2456302, CAS 1174130-61-0 , free sample, welcome to ask:

2019 CHINA CPHI  E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.

R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com